Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Lidocaine QuickStrips** (often branded as LQS) are professionally used, muco‑adhesive oral thin‑film strips containing lidocaine as a topical local anesthetic for dental procedures. The product is based on Rapid Dose Therapeutics’ QuickStrip film technology, which uses a film‑forming matrix to deliver micronized lidocaine rapidly through the oral mucosa, providing localized surface anesthesia without needles for pain‑free, non‑intrusive dental treatment.[8][9][11][13] Lidocaine in this formulation acts as an amide‑type local anesthetic that blocks voltage‑gated sodium channels in neuronal membranes, stabilizing the membrane and preventing initiation and conduction of nerve impulses, thereby producing reversible loss of sensation at the application site.[7] LQS strips are designed for application to oral mucosa by dental professionals to numb tissue before injections, scaling, or other procedures, particularly in patients who prefer or require needle‑free topical anesthesia.[9][11][13]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Lidocaine QuickStrips.